R501 – R502 Aortic Root Cannulae with and without Vent Line (R501-15, R501-20, R501-26; R502-15, R502-20, R502-26)
by Sorin Group Italia S.R.L. 510(k)
Active
510(k) K240193
Overview
The R501 – R502 Aortic Root Cannulae are vascular cannulas designed for cardiopulmonary bypass procedures. These devices facilitate arterial perfusion by connecting to the aortic root, ensuring efficient blood flow during open-heart surgeries. The cannulae are available in variants with and without integrated vent lines, allowing for tailored use depending on surgical requirements. Their construction supports secure attachment to the aorta while minimizing trauma to the vessel wall.
These cannulae are supplied as single-use, sterile devices intended for use in controlled surgical environments such as operating rooms. They are classified as Class II medical devices under FDA regulations and have received Special 510(k) clearance. Each variant (R501 or R502) is available in specific sizes (15, 20, or 26), ensuring compatibility with different patient anatomies. Storage instructions require protection from contamination and adherence to manufacturer guidelines for shelf life.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK240193 | Date22 Feb 2024 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DWF
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.4210
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Other devices from Sorin Group Italia S.R.L.
Questions
What are the key differences between the R501 and R502 aortic root cannulae, and how do I choose between them?
The R501 and R502 cannulae share the same design purpose—facilitating arterial perfusion during cardiopulmonary bypass—but differ in whether they include an integrated vent line. The R501 models (R501-15, R501-20, R501-26) are designed without a vent line, while the R502 variants (R502-15, R502-20, R502-26) include one. Choose based on surgical requirements: opt for R502 if venting is needed to manage aortic root pressure or debris, and R501 if a simpler setup suffices. Both are single-use, sterile, and sized for compatibility with different patient anatomies.
Are these cannulae reusable, or are they intended for single-use only?
These cannulae are explicitly designed for single-use only in controlled surgical environments like operating rooms. The manufacturer’s instructions emphasize sterility and controlled use, so reuse is not recommended or supported. Discarding after one procedure ensures compliance with sterile field protocols and maintains patient safety.
What sizes are available, and how do I determine the correct size for a patient?
The cannulae come in three sizes for each variant: 15, 20, and 26. Selection depends on the patient’s aortic root diameter, which should be measured preoperatively. The R501-15/R502-15 is suited for smaller roots, while the R501-26/R502-26 accommodates larger anatomies. Consulting preoperative imaging or surgical guidelines ensures proper sizing to balance perfusion efficiency and vessel trauma.
How should these cannulae be stored to maintain sterility and functionality?
Storage requires protection from contamination and adherence to the manufacturer’s shelf-life guidelines. Keep the sterile packaging intact in a clean, dry environment away from direct sunlight or extreme temperatures. Avoid exposure to moisture or chemical fumes, as these could compromise sterility or material integrity. Follow the expiration date on the packaging to ensure optimal performance.
What regulatory pathway was followed for clearance of these devices, and what does that mean for clinicians?
The R501–R502 cannulae received Special 510(k) clearance under the FDA’s Substantially Equivalent determination, classified as Class II devices. This means the FDA reviewed them against a predicate device (likely a similar aortic root cannula) to confirm safety and effectiveness for their intended use in cardiopulmonary bypass procedures. Clinicians can rely on this pathway as evidence of regulatory scrutiny, though local institutional protocols should still govern procurement and use.